Shanghai's pediatric hospitals yesterday started to remove a GlaxoSmithKline antibiotic treating children's upper respiratory diseases and urinary tract infection from their pharmacies and inform parents that they will give full reimbursement if returning the drug.The emergency actions were launched after the State Food and Drug Administration issued a statement on its website yesterday, requirin
Published News » Pharmaceutical
Pharma: China orders recall of drug over toxic fears
Posted by admin (#1) 231 days ago (http://www.mychinab2b.net)Food Safety: Watchdogs target fake drugs and tonics
Posted by admin (#1) 234 days ago (http://www.mychinab2b.net)
MORE than 300 batches of fake drugs were seized by city watchdogs and police last year, a conference heard yesterday.Producers of the 306 counterfeit lines have been treated according to the law, said Shanghai Food and Drug Administration officials.
Traditional medicine prices are elixir for sellers
Posted by admin (#1) 409 days ago (http://www.mychinab2b.net)
Trader hoarding, supply shortages drive up prices, increasing profitsThe year 2010 has seen enormous fluctuations in the price of traditional Chinese herbal medicines, price changes that have put pressure on people who need them for their health, but have benefited traders in the time-honored remedies.....
The country's biopharmaceutical industry needs to tighten quality control measures and maintain its own standards to overcome barriers in overseas markets as well as secure an emerging domestic one, officials have said.
"Quality problems in food and pharmaceutical products will have a lethal effect on consumer confidence. The melamine-tainted milk scandal provided a negative example," Liu Zhan
"Quality problems in food and pharmaceutical products will have a lethal effect on consumer confidence. The melamine-tainted milk scandal provided a negative example," Liu Zhan
Chinese pharma sales to boost global demand
Posted by admin (#1) 484 days ago (http://www.chinadaily.com.cn)
Global pharmaceutical sales may rise 5 to 7 percent next year to $880 billion on soaring demand in developing nations led by China as it becomes the world's third-largest drug market, according to IMS Health Inc.
The 2011 projection compares with this year's 4 to 5 percent growth in drug sales to $840 billion, the research company based in Norwalk, Connecticut, said in a report released on Oct
The 2011 projection compares with this year's 4 to 5 percent growth in drug sales to $840 billion, the research company based in Norwalk, Connecticut, said in a report released on Oct
Superbug under microscope -- Shanghai Daily | 上海日报
Posted by admin (#1) 534 days ago (http://www.shanghaidaily.com)
SCIENTISTS from Shanghai Institute of Materia Medica under the Chinese Academy of Sciences have begun research into a new superbug which resists almost all antibiotics, institute officials said yesterday.
The bacteria, believed to have originated in India and which spread to other parts of the world after people traveled there for cheaper medical services, has so far infected 170 peo
The bacteria, believed to have originated in India and which spread to other parts of the world after people traveled there for cheaper medical services, has so far infected 170 peo
Charles River terminates WuXi PharmaTech buy
Posted by admin (#1) 554 days ago (http://www.chinadaily.com.cn)
Shareholder objection scuppered deal, says American company
American medical research equipment and services company Charles River Laboratories International Inc on Friday abandoned its $1.6 billion takeover of WuXi PharmaTech (Cayman) Inc, citing opposition from its shareholders to the deal.
New York-listed WuXi PharmaTech is a pharmaceutical and biotechnology research and developme
American medical research equipment and services company Charles River Laboratories International Inc on Friday abandoned its $1.6 billion takeover of WuXi PharmaTech (Cayman) Inc, citing opposition from its shareholders to the deal.
New York-listed WuXi PharmaTech is a pharmaceutical and biotechnology research and developme
Merck begins work on new unit
Posted by admin (#1) 572 days ago (http://www.chinadaily.com.cn)
Drugmaker Merck Sharp & Dohme (MSD) started work on a new manufacturing site in Hangzhou on Monday as part of its expansion plans in China.
The 70,000 sq m manufacturing site in Hangzhou Economic and Technological Area has been set up with a total investment of 1.1 billion yuan and is one of the largest pharmaceutical packaging projects undertaken by Merck in recent times.
The unit is expec
The 70,000 sq m manufacturing site in Hangzhou Economic and Technological Area has been set up with a total investment of 1.1 billion yuan and is one of the largest pharmaceutical packaging projects undertaken by Merck in recent times.
The unit is expec
« previous1 next »
